Engineered peptides show promise in cancer immunotherapy

FHS
April 22, 2024
11:49 am

In a new study published today in Nature Biomedical Engineering, researchers at The University of Texas MD Anderson Cancer Center have designed a new method for developing immunotherapy drugs using engineered peptides to elicit a natural immune response inside the body.

EC approves BeiGene’s Brukinsa combo for follicular lymphoma

Share this article The latest approval for follicular lymphoma treatment marks the fourth indication for Brukinsa in the European Union. Credit: fizkes / Shutterstock.com. The

November 20, 2023

Siemens Healthineers confident it can cope with Trump tariffs

Siemens Healthineers CEO Bernd Montag said Wednesday the company is “very, very well positioned” for “a U.S. versus China situation” that could arise when Donald

November 7, 2024

Lead House sponsor of WuXi-linked bill to leave Congress early

Rep. Mike Gallagher (R-WI), the lead sponsor of a closely watched bill that would prevent many US biopharma companies from doing business with WuXi and

March 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.